Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120144117 | 12014411 | 7 | F | 20160124 | 20160711 | 20160205 | 20160720 | EXP | GB-ALEXION PHARMACEUTICALS INC-A201600591 | ALEXION | 73.63 | YR | F | Y | 0.00000 | 20160720 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120144117 | 12014411 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | UNK | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||||
| 120144117 | 12014411 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | P0004002 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
| 120144117 | 12014411 | 3 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | P0004102 | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||||
| 120144117 | 12014411 | 4 | C | TAZOCIN | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 400, UNK, TID | 0 | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120144117 | 12014411 | 1 | Paroxysmal nocturnal haemoglobinuria |
| 120144117 | 12014411 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120144117 | 12014411 | HO |
| 120144117 | 12014411 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120144117 | 12014411 | Alopecia | |
| 120144117 | 12014411 | Dysphagia | |
| 120144117 | 12014411 | Dyspnoea | |
| 120144117 | 12014411 | Fall | |
| 120144117 | 12014411 | Fatigue | |
| 120144117 | 12014411 | Fracture pain | |
| 120144117 | 12014411 | Hip fracture | |
| 120144117 | 12014411 | Jaundice | |
| 120144117 | 12014411 | Lower respiratory tract infection | |
| 120144117 | 12014411 | Mobility decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120144117 | 12014411 | 2 | 20130919 | 0 | ||
| 120144117 | 12014411 | 3 | 20130919 | 0 |